Home

Disease management

Read time: 5 min

Congress highlights

Clinical Use of Body-Swapping! Don’t worry, it’s Virtual Reality!

Digital technologies are unfamiliar to many physicians, yet there is a huge demand for their...

Read time: 4 min

Congress highlights

Psychiatrist and patient partnership encourages trust and effective care

We have so many shared objectives – notably ensuring adequate resources are given to mental...

Read time: 3 min

Congress highlights

Treatment can benefit all severities of major depressive disorder

Whether baseline severity of major depressive disorder (MDD) influences the efficacy of...

Read time: 3 min

Congress highlights

Potential new targets in depression and schizophrenia – learnings from obesity and exercise

Weight loss and exercise increase benefit for mental health, but are difficult to achieve....

Read time: 4 min

Congress highlights

Early detection and intervention in psychosis – where are we now?

Many of those experiencing first-episode psychosis achieve clinical remission, but often with poor...

Parkinson's Disease

Read time: 4 min

A whirlwind tour of clinical trials of therapies addressing motor and non-motor symptoms in Parkinson’s disease

“There’s been lots of positive work looking at not only improving symptomatic...

Read time: 5 min

Strategies for reducing the duration of untreated psychosis

Longer duration of untreated psychosis (DUP) is related to poor clinical and functional outcomes in...

Read time: 2 min

Counting the indirect costs of psychosis

Early intervention (EI) services for people with psychosis are designed to improve outcomes,...

Read time: 3 min

What do patients want and expect from their treatment for depression?

How aligned are treatment expectations between clinicians and patients? Even in the era of...

Read time: 3 min

The effects of antipsychotic dose reduction/discontinuation on long-term outcome in FEP patients

Patients with FEP often ask whether they can discontinue their medication after a period of...

Read time: 5 min

Changing the course of schizophrenia: biology, psychology and livelihood

How to manage and mitigate some long-term problems associated with schizophrenia, and improve...

Read time: 1 min

Early use of a long acting injectable antipsychotic shortens hospital stay for acute schizophrenia

Average hospital stay for patients treated with a long-acting injectable (LAI) antipsychotic...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country